Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1<i>H</i>-pyrazol-4-yl)({[(2<i>S</i>)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational Framework
John R. Doedens(Univera (United States)), Christopher A. Gabel(Community Health Systems - Lutheran Hospital), Christine Diamond(University of North Carolina at Chapel Hill), Andy Billinton(Chelmsford and Essex Hospital), MyTrang Nguyen(University of North Carolina at Chapel Hill), Beverly H. Koller(University of North Carolina at Chapel Hill), Heather Wescott(University of North Carolina at Chapel Hill), Pamela J. Smolak(Benjamin Franklin Institute of Technology), David Harrison(Chelmsford and Essex Hospital), Alan P. Watt(Essex Cardiothoracic Centre), Ken Schooley
Cited by 8
Related Papers
Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation
|Cell Death and Differentiation|2015|308
Role of gammaENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism.
|Journal of Clinical Investigation|1998|255
Impaired Host Defense in Mice Lacking ONZIN
|The Journal of Immunology|2007|92
Ubiquitin Ligase Substrate Identification through Quantitative Proteomics at Both the Protein and Peptide Levels
|Journal of Biological Chemistry|2011|85
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62